Home » Evotec, Dow AgroSciences Enter Proteomics Service Deal

Evotec, Dow AgroSciences Enter Proteomics Service Deal

Jul 09, 2013
|
staff reporter

NEW YORK (GenomeWeb News) – Evotec today announced a collaboration to support the development of compounds in development at Dow AgroSciences.

As part of the deal, Evotec will provide its quantitative chemical proteomics services to "de-convolute phenotypic screening results" obtained by Dow AgroSciences, a wholly owned subsidiary of Dow Chemical.

Financial and other terms were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Concentration of Rare Disease

Polygamy amplified a rare genetic disease in area near Arizona-Utah border, BBC Future reports.

Unexpected Findings

Genetic ancestry testing led one woman to learn that her father and another baby boy had been switched at birth, the Washington Post reports.

Make it a Bit Fuzzy

Simple de-identification methods can protect information in a database from attackers, a new study suggests.

This Week in Science

In Science this week: approach to visualize chromatin structure in nuclei, and more.

What's Popular?

In Proteomics & Protein Research

  1. OTraces Develops Early Cancer Diagnostics Based on Signal-Enhanced Protein Markers

    Premium

  2. Statistical Design Remains Sticking Point for Proteomics Experiments

    Premium

  3. Late-Onset Preeclampsia Markers Proposed From Proteomic Study

  4. PNNL Team Pushing Sensitivity Limits of Targeted Proteomics

    Premium

  5. Waters Q2 Revenues Grow 4 Percent

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.